logo
DC leads blood donation drive as Jorhat celebrates 42nd District Day

DC leads blood donation drive as Jorhat celebrates 42nd District Day

Time of India3 days ago
Dibrugarh: Jorhat DC Jay Shivani led by example as he rolled up his sleeves and donated blood at the Jorhat Medical College and Hospital (JMCH) on Monday, officially launching the blood donation campaign as part of the 42nd Jorhat District Day celebrations from June 30 to July 3.
Tired of too many ads? go ad free now
The DC's gesture was aimed at encouraging voluntary blood donation and raising awareness about the critical need for blood supplies in the district's healthcare facilities. His participation set the tone for what organisers hope will be a successful four-day celebration marking Jorhat's establishment as an independent district.
"Blood donation is a noble act. I urge all eligible citizens to come forward and donate blood.
This simple act of kindness can save precious lives and strengthen our community's spirit of service. Blood donation is one of the most meaningful ways we can contribute to society, and there's no better time than during our District Day celebrations to demonstrate this commitment," Shivani said after donating blood at JMCH.
The JMCH camp saw enthusiastic participation from college students, govt employees, and social workers.
The blood donation initiative extended beyond the district headquarters, as a simultaneous camp was organised at the Primary Health Centre in Mariani on Monday. Building on Monday's momentum, two additional blood donation camps are scheduled for Tuesday. One will be held at the First Referral Unit (FRU) in Teok, while another will take place at the sub-divisional hospital in Titabar.
"We have strategically placed these camps at key healthcare facilities to maximise participation and ensure the collected blood reaches where it's needed most.
Tired of too many ads? go ad free now
The response from volunteers has been encouraging, and we expect even greater participation in the coming days," a health official said.
The blood donation drive is among several events planned to commemorate Jorhat's 42nd District Day. On July 1, 1983, Jorhat (then a sub-division) was carved out of Sivasagar district and made into a separate district. The district administration has lined up cultural performances, literary events, and sports competitions to mark the occasion. Local artists, students, and community groups will participate in festivities showcasing Jorhat's rich heritage.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DC leads blood donation drive as Jorhat celebrates 42nd District Day
DC leads blood donation drive as Jorhat celebrates 42nd District Day

Time of India

time3 days ago

  • Time of India

DC leads blood donation drive as Jorhat celebrates 42nd District Day

Dibrugarh: Jorhat DC Jay Shivani led by example as he rolled up his sleeves and donated blood at the Jorhat Medical College and Hospital (JMCH) on Monday, officially launching the blood donation campaign as part of the 42nd Jorhat District Day celebrations from June 30 to July 3. Tired of too many ads? go ad free now The DC's gesture was aimed at encouraging voluntary blood donation and raising awareness about the critical need for blood supplies in the district's healthcare facilities. His participation set the tone for what organisers hope will be a successful four-day celebration marking Jorhat's establishment as an independent district. "Blood donation is a noble act. I urge all eligible citizens to come forward and donate blood. This simple act of kindness can save precious lives and strengthen our community's spirit of service. Blood donation is one of the most meaningful ways we can contribute to society, and there's no better time than during our District Day celebrations to demonstrate this commitment," Shivani said after donating blood at JMCH. The JMCH camp saw enthusiastic participation from college students, govt employees, and social workers. The blood donation initiative extended beyond the district headquarters, as a simultaneous camp was organised at the Primary Health Centre in Mariani on Monday. Building on Monday's momentum, two additional blood donation camps are scheduled for Tuesday. One will be held at the First Referral Unit (FRU) in Teok, while another will take place at the sub-divisional hospital in Titabar. "We have strategically placed these camps at key healthcare facilities to maximise participation and ensure the collected blood reaches where it's needed most. Tired of too many ads? go ad free now The response from volunteers has been encouraging, and we expect even greater participation in the coming days," a health official said. The blood donation drive is among several events planned to commemorate Jorhat's 42nd District Day. On July 1, 1983, Jorhat (then a sub-division) was carved out of Sivasagar district and made into a separate district. The district administration has lined up cultural performances, literary events, and sports competitions to mark the occasion. Local artists, students, and community groups will participate in festivities showcasing Jorhat's rich heritage.

Belapur to get 500-bed super specialty hosp post CRZ nod
Belapur to get 500-bed super specialty hosp post CRZ nod

Time of India

time6 days ago

  • Time of India

Belapur to get 500-bed super specialty hosp post CRZ nod

Navi Mumbai: The state govt approved construction of a 500-bed super-specialty hospital in Belapur to be built in phases. The Navi Mumbai Municipal Corporation (NMMC) received directives to commence this significant project, which aims to enhance public healthcare services in Navi Mumbai. NMMC Commissioner Kailas Shinde confirmed obtaining essential permissions, including environment clearance and new development plan approval. The initial phase involves creating a 100-bed facility at a cost of Rs 250 crore. A previous tender process was suspended due to a High Court PIL regarding environment clearance and development plan approval issues. With current govt authorisation, NMMC plans to present the acquired permissions to the court to proceed with the public hospital construction. "The tender validity was extended and opening of the bidding will commence shortly. The govt urged swift construction initiation for public benefit," Shinde stated. "The comprehensive project, valued at Rs 800 crore, encompasses a medical college and super-specialty hospital with 500 beds. Phase one involves establishing a 100-bed super-specialty hospital at Rs 250 crore. Phase two, budgeted at Rs 550 crore, includes medical college construction and hospital expansion from 100 to 500 beds," explained Belapur MLA Manda Mhatre, who communicated with the chief minister for approval. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai The project faced challenges with partial land falling under the Coastal Regulation Zone (CRZ), requiring clearance. Additionally, NMMC's new draft Development Plan (DP) awaited state approval. "We secured both DP approval and CRZ clearance, clearing construction obstacles," confirmed Shinde. A civic official noted that while the plot was previously designated as a playground in the old DP, NMMC's new DP redesignated it for healthcare facilities. Phase one completion is estimated at 3-4 years. Cidco allocated approximately 32,000 square metres at plot 4, sector 15A, adjacent to civic headquarters in Belapur, for the medical college and super-specialty hospital. NMMC paid Rs 88 crore to Cidco for the land. "The development will utilise 22,000 square metres beyond CRZ restrictions, with approval secured. The remaining 10,000 square metres under CRZ remains non-developable," NMMC clarified. "The pandemic highlighted the necessity for public healthcare facilities when Covid patients struggled to access affordable treatment and specialist care," Mhatre noted. Cidco sources indicate the plot's designation in NMMC's draft DP as a park could be modified for healthcare purposes. However, local residents who use the space as a recreational area expressed opposition.

BJ Medical College to undertake ‘targeted' genome sequencing of TB samples to get accurate picture of mutation
BJ Medical College to undertake ‘targeted' genome sequencing of TB samples to get accurate picture of mutation

Time of India

time23-06-2025

  • Time of India

BJ Medical College to undertake ‘targeted' genome sequencing of TB samples to get accurate picture of mutation

1 2 3 Pune: BJ Medical College and Sassoon General Hospital will now undertake 'targeted' genome sequencing of 50 tuberculosis samples. These samples would be sequenced as per World Health Organisation (WHO)'s genome Atlas to analyse the genetic makeup of mycobacterium tuberculosis, the bacterium that causes TB. BJ Medical College is now undertaking 'targeted' genome sequencing of samples from 50 TB patients to get a more accurate picture of mutation in the bacteria. Targeted genome sequencing involves focusing on specific, predefined regions of genome for sequencing, rather than sequencing the entire genome (whole-genome sequencing). This helps researchers and clinicians who want to investigate specific genes or genomic regions of interest. The college had carried out genome sequencing during Covid-19 pandemic. As per WHO, India has the highest burden of TB, with two deaths occurring every three minutes from tuberculosis (TB). Also, India accounts for almost 26% of drug-resistant TB cases from across the world. To expedite TB elimination, the central govt's Dare2eraD TB programme (data driven research to eradicate TB), launched on March 24, 2022 undertook whole genome sequencing of 32,000 TB samples to identify drug resistance and improve treatment outcomes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Adidas Three Shorts With 60% Discount, Limited Stock Available Original Adidas Shop Now Undo As part of this initiative, BJ Medical College had sent 1,000 samples to the department of biotechnology. Dr Rajesh Kartyakarte, head of microbiology department at the college, said, "The central govt's programme entails undertaking whole genome sequencing, which is very time consuming and expensive. However, we are now aiming to focus on targeted 'genome sequencing' for which we will refer to WHO's genome atlas. TB's genome is very big and so it is time consuming but with targeted sequencing we can find the type of mycobacterium and the exact drug resistance. If a particular drug acts on a certain protein and that protein has mutated, it means that the bacteria is resistant to that drug. We have received funding for the same and will soon be able to undertake targeted genome sequencing, maybe in a month or two, once we procure the kits." Dr Sanjay Gaikwad, head of pulmonology department at BJ Medical College, said, "It is very crucial to know whether the patient is suffering from any drug resistance and, if they are, then we need to know from which drug. Based on this information, the drug treatment regime is determined. As of now, we use CBNAAT tests to determine the drug-resistant TB. With the help of this test, we can know whether it is R-resistant or R-sensitive or H-resistant or H-sensitive. " CBNAAT, or cartridge-based nucleic acid amplification test, is a rapid molecular diagnostic test primarily used for diagnosing tuberculosis (TB) and detecting rifampicin resistance, an indicator of MDR-TB. BOX – 28% (28 lakh) of world's TB cases are diagnosed in India every year – 3,31,000 deaths due to TB in the country in 2022 – The Centre's goal is to eliminate TB by 2025 – Drug-resistant TB rate is 7% to 10% Pune: BJ Medical College and Sassoon General Hospital will now undertake 'targeted' genome sequencing of 50 tuberculosis samples. These samples would be sequenced as per World Health Organisation (WHO)'s genome Atlas to analyse the genetic makeup of mycobacterium tuberculosis, the bacterium that causes TB. BJ Medical College is now undertaking 'targeted' genome sequencing of samples from 50 TB patients to get a more accurate picture of mutation in the bacteria. Targeted genome sequencing involves focusing on specific, predefined regions of genome for sequencing, rather than sequencing the entire genome (whole-genome sequencing). This helps researchers and clinicians who want to investigate specific genes or genomic regions of interest. The college had carried out genome sequencing during Covid-19 pandemic. As per WHO, India has the highest burden of TB, with two deaths occurring every three minutes from tuberculosis (TB). Also, India accounts for almost 26% of drug-resistant TB cases from across the world. To expedite TB elimination, the central govt's Dare2eraD TB programme (data driven research to eradicate TB), launched on March 24, 2022 undertook whole genome sequencing of 32,000 TB samples to identify drug resistance and improve treatment outcomes. As part of this initiative, BJ Medical College had sent 1,000 samples to the department of biotechnology. Dr Rajesh Kartyakarte, head of microbiology department at the college, said, "The central govt's programme entails undertaking whole genome sequencing, which is very time consuming and expensive. However, we are now aiming to focus on targeted 'genome sequencing' for which we will refer to WHO's genome atlas. TB's genome is very big and so it is time consuming but with targeted sequencing we can find the type of mycobacterium and the exact drug resistance. If a particular drug acts on a certain protein and that protein has mutated, it means that the bacteria is resistant to that drug. We have received funding for the same and will soon be able to undertake targeted genome sequencing, maybe in a month or two, once we procure the kits." Dr Sanjay Gaikwad, head of pulmonology department at BJ Medical College, said, "It is very crucial to know whether the patient is suffering from any drug resistance and, if they are, then we need to know from which drug. Based on this information, the drug treatment regime is determined. As of now, we use CBNAAT tests to determine the drug-resistant TB. With the help of this test, we can know whether it is R-resistant or R-sensitive or H-resistant or H-sensitive. " CBNAAT, or cartridge-based nucleic acid amplification test, is a rapid molecular diagnostic test primarily used for diagnosing tuberculosis (TB) and detecting rifampicin resistance, an indicator of MDR-TB. BOX – 28% (28 lakh) of world's TB cases are diagnosed in India every year – 3,31,000 deaths due to TB in the country in 2022 – The Centre's goal is to eliminate TB by 2025 – Drug-resistant TB rate is 7% to 10%

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store